As we have shown EDEM3 to be a cyto-protective against ER stressors, we suggest that targeting of EDEM3, shown here through gene knockdown, may be an effective strategy to sensitise cancer cells to ER stress-inducing agents. This evidence concerns the gene EDEM3 and cancer.